Rapid, Large Volume Subcutaneous Administration of Biologics Using the ENHANZE® Drug Delivery Technology
ENHANZE® technology (rHuPH20 hyaluronidase) is a globally validated drug delivery technology currently used in 4 approved commercial products and is being evaluated in over 10 other drugs under development. Clinical and commercial experience demonstrate that rHuPH20 can successfully facilitate rapid, large volume subcutaneous (SC) delivery of co-administered drugs while maintaining their therapeutic efficacy and safety. The technology facilitates and optimizes SC drug delivery of co-administered drugs by locally depolymerizing hyaluronan (HA) in the SC space, enabling rapid administration of large volumes of the co-administered therapeutic agent. ENHANZE® may also offer a more positive experience for health care professionals and their patients.